XML 34 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Scienture Inc [Member]    
Schedule of Deferred Tax Assets and Related Valuation Allowance

The impact of the deferred tax assets and related valuation allowance on the Company’s financial statements is as follows:

 

   2023   2022 
   Year Ended December 31, 
   2023   2022 
Deferred Tax Assets          
Net operating loss carryforwards  $3,173,840   $2,491,667 
Research and development tax credits   6,635    2,705 
Property and equipment and operating lease liability   49,220    53,960 
Valuation allowance   (3,229,695)   (2,548,331)
Net deferred tax assets  $-   $-